Sandra Lee is a Partner in the Intellectual Property practice in the firm's New York office. Her practice is focused in the pharmaceutical, chemical, medical device and consumer products industries.

Sandra has a broad patent practice that focuses on client counseling and strategic portfolio development. Sandra has extensive experience with due diligence investigations on proposed transactions across a broad range of technologies, and assists her clients with IP-related agreements associated with technology transfers through acquisition or licensing opportunities.

Sandra regularly conducts freedom to operate and clearance investigations, validity/infringement assessments, and investigates inventorship disputes.

Sandra has also been involved in supporting numerous post-grant proceedings, and she regularly counsels clients in Orange Book and Hatch-Waxman related issues. Sandra has supported litigation matters from pre-suit investigation and continuing through trial.

Prior to her legal career, Sandra spent six years in biomedical research in the Department of Anesthesia at the Brigham & Women’s Hospital in Boston, investigating the interaction of opioids and benzodiazepines.